Bernadette Kleist
University of Duisburg-Essen
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Bernadette Kleist.
Neuroendocrinology | 2015
Monika Milian; Ilonka Kreitschmann-Andermahr; Sonja Siegel; Bernadette Kleist; Dagmar Führer-Sakel; Juergen Honegger; Michael Buchfelder; Tsambika Psaras
Background: To evaluate the construct and criterion validity of the Tuebingen Cushings disease quality of life inventory (Tuebingen CD-25) for application in patients treated for Cushings disease (CD). Methods: A total of 176 patients with adrenocorticotropin hormone-dependent CD (144 of them female, overall mean age 46.1 ± 13.7 years) treated at 3 large tertiary referral centers in Germany were studied. Construct validity was assessed by hypothesis testing (self-perceived symptom reduction assessment) and contrasted groups (patients with vs. without hypercorticolism). For this purpose, already existing data from 55 CD patients was used, representing the hypercortisolemic group. Criterion validity (concurrent validity) was assessed in relation to the Cushings quality of life questionnaire (CushingQoL), the Short Form 36 health survey (SF-36), and the body mass index (BMI). Results: Patients with self-perceived remarkable symptom reduction had significant lower Tuebingen CD-25 scores (i.e. better health-related quality of life) than patients with self-perceived insufficient symptom reduction (p < 0.05). Similarly, the mean scores of the Tuebingen CD-25 scales were lower in patients without hypercortisolism (total score 27.0 ± 17.2) compared to those with hypercortisolism (total score 45.3 ± 22.1; each p < 0.05), providing evidence for construct validity. Criterion validity was confirmed by the correlations between the Tuebingen CD-25 total score and the CushingQoL (Spearmans coefficient -0.733), as well as all scales of the SF-36 (Spearmans coefficient between -0.447 and -0.700). Conclusion: The analyses presented in this large-sample study provide robust evidence for the construct and criterion validity of the Tuebingen CD-25.
Endocrine | 2017
S Siegel; Renata Weber Carneiro; Michael Buchfelder; Bernadette Kleist; Agnieszka Grzywotz; Rolf Buslei; Ulrike Bingel; Georg Brabant; Thomas Schenk; Ilonka Kreitschmann-Andermahr
PurposeHeadache is a common presenting feature of patients with pituitary adenomas and other tumors of the sellar region. However, at present, it still is unclear whether the headache is actually caused by the tumor. To explore whether there is a relation, we examined in detail the headache types, their relationship to the underlying pathology, and if the headache responded to neurosurgery in a prospective study design.MethodsOne hundred twelve patients with tumors of the sellar region scheduled for neurosurgery in a single center were analyzed for presence and quality of headache before surgery and at least 3 months after surgery. Patients received headache and depression self-rating inventories, presented on a handheld computer (PainDetect®). Clinical variables thought to impact on headache were analyzed in conjunction with the inventories.ResultsFifty-nine (53%) patients reported headache in the 3 months prior to neurosurgery, 49 (44%) had headache at the time of filling in the questionnaires. The four patients with pituitary apoplexy described thunderclap headache. In the other patients diverse headache types were encountered, most frequently migraine. Untreated gonadotroph deficiency was significantly associated with absence of headache, while none of the other clinical and morphological variables related to headache. Presence of headache and disability due to headache were not significantly reduced after surgery.ConclusionApart from pituitary apoplexy we detected no specific headache type in our patient group and no significant improvement of headache after neurosurgery. Headache alone constitutes neither a valid diagnostic marker for the presence of tumors of the sellar region nor a sufficient indication for tumor removal.
Endocrine Practice | 2017
Ilonka Kreitschmann-Andermahr; Michael Buchfelder; Bernadette Kleist; Johannes Kohlmann; Christa Menzel; Rolf Buslei; Maria Kołtowska-Häggsträm; Christian J. Strasburger; Sonja Siegel
OBJECTIVE Even if treated, acromegaly has a considerable impact on patient quality of life (QoL); despite this, the exact clinical determinants of QoL in acromegaly are unknown. This study retrospectively examines a cohort of treated patients with acromegaly, with the aim of identifying these determinants. METHODS Retrospective survey analysis, with 165 patients included in the study. All patients completed a survey, which included demographic data and the clinical details of their disease, the Short Form-36 Health Survey (SF-36), the revised Beck Depression Inventory (BDI-II), and the Bern Embitterment Inventory (BEI). Stepwise regression was used to identify predictors of QoL. RESULTS The strongest predictors of the physical component score of the SF-36 were (in order of declining strength of association): Delay between first presentation of the disease and diagnosis, body mass index (BMI), number of doctors visited before the diagnosis of acromegaly, and age at diagnosis. For the mental component score, the strongest predictors were: number of doctors visited, previous radiotherapy, and age at study entry; and, for the BDI-II score: number of doctors visited, previous radiotherapy, age at study entry, and employment status at the time of diagnosis. The following were predictors of the BEI score: number of doctors visited, and age at study entry. CONCLUSION Diagnostic delay and lack of diagnostic acumen in medical care provision are strong predictors of poor QoL in patients with acromegaly. Other identified parameters are radiotherapy, age, BMI, and employment status. An efficient acromegaly service should address these aspects when devising disease management plans. ABBREVIATIONS BDI-II = Beck Depression Inventory II BEI = Bern Embitterment Inventory BMI = body mass index IGF-1 = insulin-like growth factor 1 MCS = mental component summary (score) PCS = physical component summary (score) QoL = quality of life SDS = standard deviation score SF-36 = Short Form-36 Health Survey.
Endocrine | 2018
Ilonka Kreitschmann-Andermahr; Johannes Kohlmann; Bernadette Kleist; Ursula Hirschfelder; Rolf Buslei; Michael Buchfelder; Sonja Siegel
PurposeOro-dental pathologies (ODP) such as enlargement of the tongue, mandibular prognathism, and spaced teeth are characteristic features of acromegaly. Their frequency of occurrence during the course of the disease is largely unresolved. Purpose of this study was to assess ODP and oro-dental treatments in patients with acromegaly with regard to the length of the diagnostic process, tumor histology, and quality of life (QoL).MethodsSingle-center retrospective survey study using questionnaires on dental symptoms, diagnostic process, and treatment in patients with acromegaly operated on a growth hormone-secreting pituitary adenoma. The association between ODP and QoL was assessed using the Short-Form 36 (SF-36) Health Survey.Results145/314 patients completed the questionnaires. 80.7% were affected by any ODP, most frequently enlargement of the tongue (57.9%), spaced teeth (42.8%), mandibular growth (24.1%), and mandibular prognathism (22.1%). ODP were significantly more frequent in patients with sparsely vs. densely granulated adenomas (p = 0.045). Early diagnosis within 2 years was associated with significantly fewer ODP than later diagnosis (68.5 vs. 87.2%, p = 0.009). Treatments included dental crowns (16.6%), dental bridges (12.4%), dental implants (9.7%), dental prostheses (3.4%), orthodontal (i.e., braces, 6.9%), and surgical correction of the teeth (2.1%). Physical QoL was significantly lower in patients with ODP than in those without (p = 0.014).ConclusionIn our large series of patients, four of five patients were affected by ODP at any time during the course of the disease. The results highlight the importance of early identification and treatment of oro-dental problems in patients with acromegaly as hallmarks of the disease.
Clinics and practice | 2017
Homajoun Maslehaty; Cornelius Deuschl; Bernadette Kleist; Sophia Göricke; Ulrich Sure; Oliver Müller
The aim of this cross sectional anatomical study is to determine the distribution of the defined anatomical variations of the Sylvian fissure (SF) in a normal population and to analyze its bilateral superposable presentation. Furthermore, we examined the course of the middle cerebral artery (MCA) and the division of the MCA branches in relation to the SF types. A total of 300 cranial CT scans - 100 CT angiography datasets and 86 MRIs of patients without intracranial pathologies - were reviewed. The SF was categorized in five types based on Yasargils description and our previous publication. The length, diameter and branches of the MCA were measured and compared to the SF types. SPSS 23.0 for Windows® was used for statistical analysis. We analyzed data of 300 patients (171 male, 129 female; mean age 51.6years). Symmetric and mirror-imaged coherence of the SF was found in 266 patients (88.7%, χ2(8)=3.04, p=0.932). The distribution of the SF types showed significant differences in patients younger than 60 years compared to older patients. A bifurcation was observed in 72.0%. A trifurcation was observed in 12.0% and a false bifurcation in 16.0% of patients. There was no significant difference of the measured diameters or length of the M1 segments according to the SF types. In this CT and MRI based anatomical study we could show that a twisted and narrow SF occurred more frequently in patients younger than 60 years of age. The SF has a high congruence intra-individually. The anatomical condition might influence the size and configuration of the proximal MCA, which in turn might influence the surgeon’s choice of the approach to the SF. Preoperative evaluation on the basis of the presented data, may help to decide for an appropriate approach to the SF.
European Journal of Endocrinology | 2015
Ilonka Kreitschmann-Andermahr; Tsambika Psaras; Maria Tsiogka; Daniel Starz; Bernadette Kleist; Sonja Siegel; Monika Milian; Johannes Kohlmann; Christa Menzel; Dagmer Führer-Sakel; Juergen Honegger; Ulrich Sure; Oliver Müller; Michael Buchfelder
Pituitary | 2016
Ilonka Kreitschmann-Andermahr; S Siegel; Bernadette Kleist; Johannes Kohlmann; Daniel Starz; Rolf Buslei; Maria Koltowska-Haggstrom; Christian J. Strasburger; Michael Buchfelder
Pituitary | 2016
Sonja Siegel; Monika Milian; Bernadette Kleist; Tsambika Psaras; Maria Tsiogka; Dagmar Führer; Maria Koltowska-Haggstrom; Jürgen Honegger; Oliver Müller; Ulrich Sure; Christa Menzel; Michael Buchfelder; Ilonka Kreitschmann-Andermahr
Neurosurgical Review | 2015
Neriman Özkan; Ilonka Kreitschmann-Andermahr; Sophia Luise Goerike; Karsten Wrede; Bernadette Kleist; Klaus-Peter Stein; Oliver Gembruch; Ibrahim Erol Sandalcioglu; Isabel Wanke; Ulrich Sure
Clinical Neurology and Neurosurgery | 2017
Agnieszka Grzywotz; Bernadette Kleist; Lars Möller; Volkmar Hans; Sophia Göricke; Ulrich Sure; Oliver Müller; Ilonka Kreitschmann-Andermahr